Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetix's Medical Advi...(unctional relationship of abnormalities ...)

Date:10/9/2007

unctional relationship of abnormalities of the inflammatory process with focus on regulation of phagocytic cells, in the etiology and pathogenesis of periodontal diseases. He is best known for his work on the pathways of resolution of inflammation and pathogenesis of periodontal diseases, neutrophil biology, and clinical research.

"We are very excited to add an individual of Dr. Van Dyke's caliber and experience to our Medical Advisory Board", said Mr. William Spencer, President of Imagenetix. "We believe his joining our Medical Advisory Board validates the success of our periodontal studies at Boston University. We also believe that he will be instrumental in helping us through the FDA process for our periodontal compound 1-TDC which we feel could be a major breakthrough in prevention of periodontal disease."

About Imagenetix

Based in San Diego, California, Imagenetix, (OTC Bulletin Board: IAGX) is an innovator of scientifically tested, natural-based, proprietary bioceutical products developed to enhance human health on a global basis. Imagenetix develops, formulates and private-labels propriety over-the-counter topical creams, skincare products and nutritional supplements to be marked globally through multiple channels of distribution. In addition, the company develops patentable compounds for entering into licensing agreements with pharmaceutical partners. Imagenetix is the creator of Inflame Away(TM)- Celadrin(R), which has been clinically tested to relieve osteoarthritis pain and significantly improve joint health. For more information, please visit, http://www.imagenetix.net.

This document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements are subject to risks and uncertainties that could cause actual results to vary materially from those p
'/>"/>

SOURCE Imagenetix, Inc. Copyright©2007 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. OpGen adds Thomas Pyle and James Ogle to board of directors
2. The birth of biotech: San Francisco, Boston, Geneva or Chicago?
3. Wicab to present BrainPort at Boston conference
4. Boston equity firm becomes majority owner of Cedarburg-based Mortgagebot
5. Boston entrepreneur to enliven Milwaukee angel group
6. Fermentation Cell Culture: University Style
7. Fueling our economy with the University of Wisconsin
8. CIO Leadership Series: Ed Meachen, University of Wisconsin System
9. University, business leaders convene in Wausau
10. University of South Florida expands GE Healthcare relationship
11. State and university form network for entrepreneurial outreach